Patent Assignment
Reel/Frame 044719/0767
Security Interest
Recorded: 2018-01-24
Pages: 14
Assignor
ACERUS BIOPHARMA INC.
Executed: 2017-12-06
Assignee
QUANTIUS INC.
1 YONGE STREET, SUITE 1801, TORONTO, ONTARIO, M5E 1W7, CANADA
Covered Properties
(8)
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/442,949 →
Publication:
US 2015/0297733
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/508,904 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
14/536,130 →
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/713,706 →
Publication:
US 2016/0113946
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application:
61/802,724 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application:
61/802,727 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application:
61/802,737 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application:
61/802,739 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 25, 2014
From: TRIMEL BIOPHARMA SRL
To: MIDCAP FUNDING V, LLC
Reel/Frame 033416/0897 →
Assignment of Assignor's Interest
Oct 9, 2015
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036827/0897 →
Change of Name
Dec 5, 2017
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 044693/0936 →
Release of Security Interest
Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Intellectual Property Security Agreement
Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Release of Security Interest
Nov 2, 2018
From: QUANTIUS INC.
To: ACERUS PHARMACEUTICALS CORPORATION; ACERUS LABS INC.; ACERUS BIOPHARMA INC.
Reel/Frame 047399/0698 →
Assignment of Assignor's Interest
May 13, 2021
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 056233/0589 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056283/0289 →
Gudaitis Declaration Supporting Chain of Title
May 13, 2021
From: TRIMEL BIOPHARMA INC.
To: ACERUS BIOPHARMA INC.
Reel/Frame 056252/0740 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056284/0111 →
Change of Name
May 13, 2021
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 056238/0484 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056285/0129 →